Intrinsic Value of S&P & Nasdaq Contact Us

Biodexa Pharmaceuticals Plc BDRX NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • GB • USD

SharesGrow Score
27/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

There have been 6 recent insider transactions recorded for Biodexa Pharmaceuticals Plc (BDRX), including 0 buys and 0 sells.

Notable insiders with recent activity include Turton Simon, Stamp Stephen Anthony, Powell Fiona Mary. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.

Insider Transactions — BDRX

Date Name Role Transaction Shares Avg. Price Value Shares Owned
2026-03-18 Turton Simon Director Unknown 288 $475.00 $136.8K -
2026-03-18 Stamp Stephen Anthony Chief Executive Officer Unknown 15,000 $5.40 $81K -
2026-03-18 Powell Fiona Mary Chief Financial Officer Unknown 8,750 $7.41 $64.84K -
2026-03-18 Merchant Ann Louise Director Unknown 288 $475.00 $136.8K -
2026-03-18 De Vries Simon Director Unknown 288 $475.00 $136.8K -
2026-03-18 Parker Stephen Barry Director Unknown 576 $475.00 $273.6K -
Informative Buy/Sell — open market transaction (most significant) Uninformative Buy — award, option exercise, conversion Uninformative Sell — tax withholding, award vest sale Neutral — gift, trust, expiry
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message